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Abstract: 
Our former study demonstrated that Krüppel-like Factor 7 (KLF7) is a transcription factor 
that stimulates axonal regeneration after peripheral nerve injury. Currently, we used a gene 
therapy approach to overexpress KLF7 in Schwann Cells (SCs) and assessed whether KLF7-
transfected SCs graft could promote sciatic nerve regeneration. SCs were transfected by 
AAV2-KLF7 in vitro. Mice was allografted by an acellular nerve (ANA) with either an 
injection of DMEM (ANA group), SCs (ANA+SCs group) or AAV2-KLF7-transfected SCs 
(ANA+KLF7-SCs group) to assess repair of a sciatic nerve gap. The results indicate that 
KLF7 overexpression promoted the proliferation of both transfected SCs and native SCs. The 
neurite length of the DRG explants was enhanced.Several beneficial effects were detected in 
the ANA+KLF7-SCs group including an increase in the compound action potential 
amplitude , sciatic function index  score, enhanced expression of PKH26-labeling transplant 
SCs, peripheral myelin protein 0 , neurofilaments , S-100, and myelinated regeneration nerve. 
Additionally, HRP-labeled motoneurons in the spinal cord, CTB-labeled sensory neurons in 
the DRG, motor endplate density and the weight ratios of target muscles were increased by 
the treatment while thermal hyperalgesia was diminished. Finally, expression of KLF7, NGF, 
GAP43, TrkA and TrkB were enhanced in the grafted SCs, which may indicate that several 
signal pathways may be involved in conferring the beneficial effects from KLF7 
overexpression. We concluded that KLF7-overexpressing SCs promoted axonal regeneration 
of the peripheral nerve and enhanced myelination, which collectively proved  KLF-SCs as a 
novel therapeutic strategy for injured nerves. 
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INTRODUCTION 
Although peripheral nerves can endogenously regenerate after injury, a complete nerve 
transection or proximal nerve injury are generally associated with poor outcomes with limited 
motor recovery (Lundborg, 2000; Ma et al., 2011). The reason has been ascribed to multiple 
factors including the shortage of growth-promoting molecules and an inhibitory 
microenvironment (Grinspan et al., 1996; J et al., 2004; Fang et al., 2010; Wang et al., 2012). 
Accordingly, a combinatorial strategy targeting multiple deficits is often necessary (Zhao et 
al., 2011; Gao et al., 2014; Ghayemi et al., 2014; Zhao et al., 2014). 
As a member of the zinc-finger DNA-binding protein family, Krüppel-like factors (KLFs) 
transcriptionally control numerous signaling pathways responsible for cell growth, 
proliferation, differentiation, migration, apoptosis,  and inflammation (Moore et al., 2009; 
Moore et al., 2011; Yin et al., 2015).  As a transcriptional activator, KLF7 is predominantly 
involved in many process of the nervous systems (Laub et al., 2006; Zhang et al., 2013). 
Particularly, KLF7 are key transcription factors or robust axon regeneration, neuronal 
morphogenesis, neuroblast differentiation and survival of sensory neurons (Lei et al., 2006; 
Kajimura et al., 2007; Veldman et al., 2007; Yin et al., 2015; Zhang et al., 2013).  
KLF7 has been found to be strongly activated in response to nerve injury, mediating 
axonal response to the injury (Veldman et al., 2007; Zou et al., 2009). KLF7 can promote 
both sprouting and regenerative axon growth in the corticospinal tract (CST) of adult mice 
(Blackmore et al., 2012). Our previous studies demonstrated that KLF7 promotes the axonal 
regeneration of the peripheral motor and sensory nerve (Wang et al., 2016), which suggests 
that KLF7 may play a role in enhancing the neuronal intrinsic growth capacity (Moore et al., 
2009). Additionally, it has been noted that NGF (Caiazzo et al., 2010), TrkA (Lei et al., 2001; 
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Lei et al., 2006), TrkB (Kingsbury and Krueger, 2007) and GAP43 (Blackmore et al., 2012; 
Kajimura et al., 2007) are direct KLF7 target genes. 
Schwann cells (SCs) are widely considered to be one of the best candidates for cell 
therapy of peripheral nerve injury due to their crucial role in axon regeneration, re-
myelination, producing neurotrophic factors, and organizing Büngner bands after injury 
(Shakhbazau et al., 2012; Lehmann and Hoke, 2010). The success of ANA in combination 
with SCs has revealed a promising strategy for peripheral nerve injury repair (Gravvanis et 
al., 2007; Biazar and Heidari Keshel, 2013). SCs are a strong candidate for transplantation in 
ANA in nerve gap repair due to their effectiveness in axonal regeneration in short distance 
(Moore et al., 2011). However, for nerve gaps with lengths of 10 mm or more in mice, there 
is an increasing SCs replication burden due to the low survival rate of transplanted SCs and a 
longer delay in the repopulation of the graft, likely causing reduced regeneration (Hayashi et 
al., 2007). Transcription factors have been  found to benefit SCs survival in the peripheral 
nervous (Wang et al., 2015; Huang et al., 2015; Hoben et al., 2015). KLF7-SCs delivery 
strategies have been previously employed to improve SCs quantity toward the goal of 
enhancing the efficiency of cell transplantation (Hoben et al., 2015).  However, there has 
been no investigation regarding the use of KLF7-transfected SC in anchoring or enhancing 
the therapeutic capacity of ANAs. In this study, SCs were infected by AAV2-KLF7 in vitro. 
We examined the effect of KLF7-transfected SCs on SCs proliferation and neurite outgrowth 
in DRG explants. Next, we transplanted KLF7-transduced SCs engineered into ANA to repair 
sciatic nerve gap in vivo and investigated the SCs’ survival, myelination, motor and sensory 
axon regeneration. Additionally, the expression of KLF7 and its target genes were evaluated 
in the regenerated nerve, along with locomotor outcome and electrophysiological activity. We 
hypothesized that overexpression KLF7 could up-regulate the expression of target genes such 
as NGF in transplanted SCs, enhancing SCs survival and proliferation and promoting axonal 
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regeneration, myelination and locomotor functional recovery. We report that the therapeutic 
strategy was efficacious, exhibiting superior outcomes than ANA+SCs treatment alone. 
EXPERIMENTAL PROCEDURES 
Viral vector preparation 
AAV-GFP virus containing both AAV serotype 2 Capsid and GFP was used. GFP 
expression was under the control of Cytomegalovirus immediate-early promoter (CMV) 
(AAV2-GFP, 1.0 × 1013 viral particles/ml; Vector Biolabs, Philadelphia, USA) which was 
used as a control. Mouse KLF7 sub-cloned into an AAV2 vector cassette was under the 
control of the CMV promoter (Vector BioLabs, Pennsylvania, USA; AAV-m-KLF7). 
 KLF7 transduction SCs  
SCs were seeded into a 6-well plate (5 × 105 cells/well). When cells growth has reached 
over 90% confluence, 4-6 μg/ml polybrene were added (Sigma, USA) for 30-60 min. Then 
cells were infected by AAV2-GFP (final concentration 6.5 × 109 viral particle/ml) and 
AAV2-KLF7 (6.5 × 109 viral particle/ml) for 12 h at a multiplicity of infection (MOI) (150 
μl/well) of 4.  More than 50% cells were infected (Abdellatif et al., 2006).  After three days,  
SCs were fixed and immunostained with an anti-S-100 (1:200; Sigma Aldrich, USA) and 
anti-KLF7 antibody (1:200; Novus Biologicals, Colorado, USA). 
SCs proliferation assay 
, SCs were plated with a density of 3×105 cells/mL on coverslips. 4 h after 5-ethynyl-2-
deoxyuridine (EdU) was applied, we fixed the cellsfor the EdU immunostaining. EdU Cell 
Proliferation Kit was used by following the manufacturer’s protocol (Ribobio, USA). To 
determine the EdU labeling index, We countedthe number of EdU-labeled nuclei from five 
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random fields, which thenwas divided by the number of DAPI-labeled nuclei . The assays 
were conducted in triplicate. 
We used coculture system to detect the effect of KLF7 transfection on native SC 
proliferation and the outgrowth of dorsal root ganglion (DRG) (Huang et al., 2015). To 
determine whether KLF7-SCs influenced the SCs proliferation, we seeded purified SCs or 
DRG in the bottom chamber and AAV2-GFP-SCs or AAV2-KLF7- in the top chamber. 
Three days later, the SCs proliferation in the bottom chambers was investigated.  
DRG explant cultures 
We used a coculture system to evaluate the effect of KLF7-SCs on neurite axonal 
outgrowth (Huang et al., 2015). Briefly, neonatal  rats DRGswere digested, then placed on 
coverslips, the coverslips were carefully moved to the bottom chamber, subsequently KLF7-
SCs and AAV-GFP-SCs were transferred to the top of each transwell chamber as described 
dose for 3 d, The DRG was fixation and immunostained with an antibody of neuronal marker 
β-III-tubulin (1:200; Sigma Aldrich, USA) (to identify neurite outgrowth) and DAPI (1:200; 
Sigma, USA). Neurite axonal outgrowth was measured by the average length of the five 
longest axons as described previously (Zhang et al., 2009). 
Animals 
Forty-eight C57BL/6 female mice and 24 CD1 (ICR) mice (male = 24, female = 24, 
weight range 18─22 g,  eight weeks-old,) were purchased from the Experimental Animal 
Center of China Medical University (Certification No. SCXK Liao 2003-0009).  Nerve 
donors were ICR mice and graft recipients were C57BL/6 mice. The Animal Care and Use 
Committee of China Medical University approved our experimental protocols. 
Seeding KLF7-SCs into ANA 
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Acellular nerve allografts (ANA) preparations followed previous method (Jia et al., 
2012). Briefly, bilateral sciatic nerves of  CD1 mice were were exposed. 15-mm nerve 
segments were taken. Both ends of nerves were fixed and incubated with 0.05 M Tris–HCl 
buffer supplemented with protease inhibitors (aprotinin at 0.1 μg/ml; leupeptin at 0.5 μg/ml; 
pepstatin A at 0.6 g/ml) for 4 days at 4°C. Next, DNase I (5 ng/ml) and RNase A (1 U/ml) 
were added to digest the nerves for 10 h in Tris-HCl buffer containing 3% Triton X-100 (pH 
7.4). We used distilled water to wash the nerves and immersed the ANAs in antibiotic-
supplemented phosphate-buffered saline (pH 7.4; with 100 U/ml penicillin and 26 mg/L 
gentamycin sulfate).   
Cultured SCs were labeled with a fluorescent tracking dye PKH26 tracking dye before 
grafting.  The procedure for PKH26 labeling followed the supplier's instructions (Sigma 
Chemical Co., St. Louis, USA). A total of 2×107 SCs in 100 μl complete medium was 
injected into four evenly spaced points of the nerve section using a micro-injector and 
Hamilton syringe with a 30 gauge needle. The ANA contents included 1) DMEM alone, 2) 
SCs alone (SCs), or 3) SCs infected with AAV2-KLF7 (KLF7-SCs). The ANA were then 
incubated in complete medium in a humidified atmosphere with 5％ CO2 at 37℃ for 48 h 
after which they were collected for in vivo experiments. 
Study groups and surgical procedures 
All mice were randomly divided into three groups. Group I: ANA group, ANA treated 
with DMEM alone (n = 16); Group II: ANA+SCs group, ANA treated with SCs alone control 
(n = 16); Group III: ANA+KLF7-SCs group, ANA treated with KLF7-SCs (n = 16). The 
procedures for sciatic nerve defect and ANA implantation, as well as for pre- and post-
operative animal care, are described in detail in previous publications (Li et al., 2008; Gao et 
al., 2014). Briefly, the right sciatic nerve was exposed.  The nerve was completely cut. The 
retract of stumps created a 10-mm sciatic nerve defect. The nerve defect was bridged by the 
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three different ANA graft paradigms previously described. The implant was sutured to both 
the proximal and distal nerve stumps. Post-operative cares were taken to all mice according 
to the research guideline.  
HRP and CTB retrograde neural tracing 
Retrograde tracing was performed by horseradish peroxidase conjugated to the cholera 
toxin B subunit (BHRP) according to previously published protocols (Byers et al., 2012), 
Briefly, on the 26th post-operative day, animals were re-anesthetized and the TA muscle was 
exposed and injected with BHRP (0.5 μl, 0.2%; List Biological, Inc). BHRP labeling permits 
population-level quantitative analysis of motor neurons in the L3-L5 ipsilateral ventral horns. 
To obtain an optimal labeling of motor neurons, animals were sacrificed by a lethal dose of 
Nembutal (60 mg/kg, i.p.) twenty eight hours after BHRP injection. Animals were perfused 
intracardially and fixed by cold 1% paraformaldehyde/1.25% glutaraldehyde （n = 3/each 
group）. 
On the 22th post-operative day, animals were anesthetized, when CTB (a 2% solution of 
Alexa Fluor labeled (594) cholera toxin B (CTB) (Invitrogen, USA) in PBS) was injected 
into the TA muscle (Hirakawa et al., 1992). Mice were euthanasized six days after injection 
of neural tracer. (n = 3/each group). 
Cells labeled by HRP and CTB were identified and counted under microscope at a 
final magnification of × 400. All labeled cells were counted in each section and the numbers 
of labeled cells totaled. Measurements of more than 200 labeled motor neurons in L3-L5 
Rexed lamina IX of the ipsilateral ventral horns and sensory neurons in the ipsilateral L3-L6 
DRG had an average cell diameter of 27.2 and 25.6/μm, respectively (da Silva et al., 1985). 
Analysis of sciatic function index (SFI)  
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The sciatic function index (SFI) was used to measure the function of regenerated 
sciatic nerve  (Kanaya et al., 1996). A experimental performer blinded to treatment evaluated 
sciatic nerve function every week. The rats’ hind feet were inked and the rats walked across a  
tunnel to record the footprints on paper paved on the bottom of the tunnel. The length 
between the third toe and heel (PL), first and fifth toe (TS), and second and fourth toe (ITS) 
were measured on the experimental side (EPL, ETS, and EITS, respectively) and the 
contralateral normal side (NPL, NTS, and NITS, respectively). The SFI was calculated as 
follows: SFI=-38.3× (EPL-NPL)/NPL+109.5 × (ETS-NTS) /NTS+13.3 × (EITS-NITS) 
/NITS-8.8. In general, an SFI value around 0 indicated normal nerve function and a value 
around -100 indicated total dysfunction.  
Hargreaves’ test  
We used a plantar test apparatus to assess heat hyperalgesia.We measured the forepaw 
withdrawal latency responding to heat stimulation (Woodland Hills, CA, USA) (Hargreaves 
et al., 1988). Testing was performed by blind perfomer. Assessments were made including 
baseline and different time points after treatment. We calculated baseline values of paw 
withdrawal by an average of 2 - 3 consecutive withdrawal latencies of both hind paws 
detected at 15-min intervals. The difference of latency between the bilateral paws was 
considered to be an index of heat sensitivity. 
Electrophysiological analysis 
All animals received electrophysiological test before sacrifice (Day 28) under 
anesthesia (pentobarbital 40 mg/kg i.p.). A pair of needle electrodes were placed at the sciatic 
notch to stimulate the nerve with single electrical pulses of 0.05 ms until supramaximal 
intensity was achieved. The compound muscle action potentials were recorded from the 
medial gastrocnemius muscle and from the plantar muscles (at the third interosseous space). 
The evoked action potentials were displayed at settings appropriate for the measurement of 
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the amplitude from baseline to peak and the latency to the onset. To normalize the data, 
values obtained from the operating hind limb were expressed as percentage of values of the 
contralateral limb for each animal. Latency period and compound action potential amplitude 
(CMAP) were then recorded (Yang et al. 2007). 
Western blotting 
Western blot analysis was performed in accordance with previous reports (Liu and 
Xu, 2006). In vivo, the SCs samples were was homogenized 3 d after AAV2-KLF7 
transfected. To evaluation the expression changes of KLF7 after grafting, normal sciatic 
nerve or the distal segments of injured sciatic nerve samples at different time points after 
grafting was homogenized in tissue homogenization. To evaluation the expression of KLF7 
and its target gene in ANA in different group. Four weeks after grafting, ANAs were 
dissected and washed in saline, the dura mater was removed and snap-frozen on dry ice, 
protein samples (20 μg) were electrophoresed on SDS-polyacrylamide gels and transferred to 
polyvinylidene difluoride membranes (Millipore, Bedford, MA).  The blots were incubated 
with primary antibodies against KLF7 (1:500; Novus Biologicals, Colorado, USA), GAP43 
(1:1000; Sigma Aldrich, Missouri, USA), NGF (1:500; sigma, USA), TrkA (1:1000; sigma, 
USA), and TrkB (1:1000; sigma, USA) overnight followed by incubation with an HRP-
conjugated secondary antibody for 1 h at room temperature (1:5000). Blots were visualized 
using the enhanced chemiluminescence (ECL) plus detection system (GE Healthcare, Little 
Chalfont, UK). 
Immunohistochemistry  
cryostat sections were cut in 25 μm-thick from the middle of the grafted  nerve (Menzel-
Glaser, Braunschweig, Germany).  Tissues were immune-stained for peripheral myelin or P0 
(1:200; Sigma Aldrich, Missouri, USA), neurofilaments or NF (1:200; Sigma Aldrich), S-100 
(1:200; Sigma Aldrich), choline acetyltransferase or ChAT (1:500; Sigma Aldrich), or 
13 
 
calcitonin gene-related peptide or CGPR (1:1000; Sigma Aldrich).The signals were 
visualized by secondary antibodies such as goat anti-rabbit IgG (FITC) or anti-mouse IgG 
(TRITC) (1:200; Jackson ImmunoResearch Laboratories, Pennsylvania, USA). The Tissues 
were scanned by MetaMorph/DP10/BX41 analytical imaging system to generate figures. The 
optical density of positive immunological signal was also analyzed. 
Histopathological analysis  
Histological analysis of nerve regeneration was performed as previously described (Jia 
et al., 2012). A transmission electron microscope (TEM) and toluidine blue staining were 
used to evaluate the regeneration of myelinated nerve, myelin sheath thickness, and axon 
diameter of nerve graft.  
Muscle wet weight ratio and motor endplate analysis 
At 28 d, the muscles of gastrocnemius and anterior tibial on both sides were harvested, 
and immediately weighed, respectively, to measure the muscles wet weight ratio  (the muscle 
wet weight of injured side/the muscle wet weight of uninjured side). 
The muscle sample was harvested from the mid-belly of TA muscles, motor endplate 
density densities were assessed after staining for acetylcholinesterase using the cholinesterase 
staining method (Byers et al, 2012).  
Statistical analysis 
       Statistical analysis was conducted using SPSS software (version 13.0; SPSS, Illinois, 
USA) where values were expressed as the mean with standard deviation.  Sample sizes were 
initially determined using statistical software to calculate the minimum total required number 
of animals or assays. All reported groups were above the minimum calculated sample size. 
Kolmogorov-Smirnov test was used to distinguish between parametric or nonparametric data, 
all parametric values were analyzed with a two-tailed Student’s t tests, or one-way ANOVA, 
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and Tukey’s post hoc test with GraphPad Prism 6.0 software. A P value of <0.05 was 
considered statistically significant. A P value of <0.05 was considered statistically significant. 
RESULTS 
Efficacy of AAV2-KLF7 gene transfer to SCs in vitro 
To identify SCs, cells were stained by S-100 and GFAP. The cytoplasm of the positively 
stained SC cells was apparent by double-labeling by S-100 and GFAP (Figure 
1A).Additionally, the morphology of the positively labeled cells was consistent with that of 
SCs observed under inverted microscope.  
We then examined AAV2-GFP infected SCs in vitro (Figure 1B).  The AAV2-GFP 
transfection of SCs was successful, with a transfection efficiency of 93.7 ± 3.09 % (Figure 
1C). Next, the transfection efficiency of AAV2-KLF7 was tested in SCs using 
immunocytochemistry and Western blotting (Figure 2). We found that control SCs expressed 
a low level of KLF7, 3 d after AAV2-KLF7 infection, the KLF7 was widely colocalized with 
SCs labeled by S100, and KLF7 was distributed both in the nuclear and cytoplasm of SCs in 
vitro (Figure. 2A). Compare to AAV-GFP-SCs, the expression of KLF7 had increased 
significantly in KLF7-SCs as detected by immunocytochemistry (Figure 2B). 
The expression of KLF7 after AAV2-KLF7 transfected was further confirmed by 
Western blots (Figure 2C). Compare to AAV2-GFP group, the expression level of KLF7 and 
NGF protein were increased in the AAV2-KLF7 group (KLF7: t4 = 19.09, P<0.001; NGF: t4 
= 4.01, P<0.05) (Figure 2D, E). This result verified that SCs have been successfully 
transfected by AAV2-KLF7 vector producing higher levels of KLF7 and its target genes NGF 
expression than the control groups. 
KLF7 overexpression promotes infected SCs proliferation, and KLF7-SCs promote 
native SCs proliferation and neurite length of DRG explants in vitro 
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We first detected the proliferation of KLF7 overexpression SCs by EdU staining at 3 
days transfection (Figure 3A, B). The EdU-positive  SCs in the AAV2-KLF7 group was 2.1 
fold higher than in the AAV2-GFP groups (t6 = 14.03, P<0.001)  (Figure 3E), suggesting that 
KLF7 overexpression promotes infected SCs proliferation. 
We next verified whether the transplanted SCs can affect native SCs (Figure 3C, D). 
There is significantly increase in the percentage of EdU-positive SCs in the Co-AAV-KLF7 
group as compared with Co-AAV-GFP group at 3 days post-transfection (t6 = 4.668, P<0.01) 
(Figure 3F). The results clearly showed KLF7-SCs promote native SCs proliferation. 
Finally, we detected whether  the KLF7-SCs can promote neurite axonal outgrowthby 
applying a coculture system of  KLF7-SCs and DRG explants (Figure 4A). The average 
length of the longest axons in Co-AAV-KLF7-SCs group  (1329±282.5 μm) is more than 
that in Co-AAV-GFP-SCs (620.4±99.88 μm) (t8 = 5.285, P<0.001) (Figure 4B). 
These results supported the interpretation that KLF7 overexpression promotes infected 
SCs proliferation, and KLF7-SCs can promote proliferation of native SCs and neurite axonal 
outgrowth. 
The expression changes of KLF7 following ANA grafting 
The expression changes of KLF7 after ANA grafting was confirmed by Western blots 
(Figure 5A). Our results showed that KLF7 protein levels were very low in the normal sciatic 
nerve. The expression of KLF7 in the distal segments of injured sciatic nerve was induced by 
1 day post-graft, peak around 1-2 week and return to normal level of the normal sciatic nerve 
at about 4 week (F5,12 = 173.5, P<0.001) (Figure 5B). Which indicated that the KLF7 is 
reactivated and involved the process of sciatic nerve regeneration after ANA grafting. 
KLF7-SCs significantly increased the expression of KLF7, NGF, GAP43, TrkA, and 
TrkB in regenerating ANA 
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 We examined KLF7 expression by Western blot in ANA tissues harvested 28 days 
after injury (Figure 6A).  In the ANA and ANA+SCs groups, a very low expression of KLF7 
was found, however, animals receiving the KLF7-SCs showed an increase in KLF7 protein 
expression (F2, 6 = 1114, P<0.001) (Figure 6B). Meanwhile, to test the effect mechanism of 
KLF7-SCs on promotion of nerve regeneration, we examined the expression of KLF7 target 
genes such as NGF, GAP43, TrkA, and TrkB in ANA tissues (Figure 6A). The results 
demonstrated that ANA+KLF7-SCs and ANA+SCs group dramatically promoted NGF, 
GAP43, TrkA, and TrkB expression in the nerve graft compared to ANA groups. Notably, the 
NGF, GAP43, TrkA, and TrkB expression in the ANA+KLF7-SCs group was more 
prominent than in the ANA+SCs group (P<0.05) (Figure 6C-F) 
The above results show that KLF7-SCs can promote expression of KLF7 and induce an 
increase in expression of target gene such as NGF, GAP43, TrkA, and TrkB in regenerating 
ANA tissues.  
KLF7-SCs promote myelinated fiber regeneration and transplant SCs survival in 
regenerating ANAs 
       To further assess myelinated fiber regeneration and transplant SC survival in regenerating 
ANA, ANAs were sectioned longitudinally and visualized by immunohistochemistry (Figure 
7A-C). The ANA from the ANA+KLF7-SCs group showed increased PKH26-labeling in SCs 
than the ANA+SCs groups, however, no expression of PKH26-labeling in SCs was detected 
in the ANA groups (F2, 15 = 70.22, P<0.001) (Figure 7A-D). In the ANA+KLF7-SC and 
ANA+SCs tissues, peripheral myelin (P0) occupied the total length of the ANA (Figure 7A, 
B), while, the ANA control tissues had shorter myelinated fibers across the ANA (Figure 7C). 
Quantification of P0 intensity verified that peripheral myelin in ANA+KLF7-SCs and 
ANA+SCs tissues were higher than that in ANA control group. Moreover, the peripheral 
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myelin in the ANA+KLF7-SCs group was higher than that in ANA+SCs group (F2, 15 = 41.59, 
P<0.001) (Figure 7E).  
Toluidine blue staining further verified that the number of myelinated fibers in the 
ANA+SCs and ANA+KLF7-SCs group was greater than in ANA group. Notably, the number 
of myelinated fibers in the ANA+KLF7-SCs group was significantly higher than the 
ANA+SCs group (F2, 15 = 24.77, P<0.001) (Figure 8A, C). Similarly, the nerve myelin sheath 
thickness and axon diameter demonstrated similar patterns of changes in the three groups 
(myelin sheath thickness: F2, 15 = 30.29, P<0.001; axon diameter: F2, 15 = 13.58, P<0.001) 
(Figure 8D, E). Furthermore, TEM analysis indicated that the degeneration of myelin sheath 
in the ANA group was pronounced than in ANA+SCs and ANA+KLF7-SCs groups (Figure 
8B). These results verified that the quantity, construction and myelination of regenerated 
nerve fibers in the ANA+KLF7-SCs group were best among all groups. 
Collectively, the above results indicate that ANA+KLF7-SCs treatment promotes 
transplant SCs survival and myelinated fiber regeneration in regenerating ANAs. 
KLF7-SCs enhance motor and sensory axonal regeneration in regenerating ANAs 
We found that S100 (a marker of myelinated SC cells) surround NF-positive axons (a 
marker of pan-neuronal) (Figure 9A), which labeled myelinated axonal. the expression of S-
100 and NF was significantly increased in the ANA+SCs and ANA+KLF7-SCs group than 
ANA group. Moreover, the expression of NF and S-100 in the ANA+KLF7-SCs group was 
higher than in the ANA+SCs group (NF: F2, 15 = 26.29, P<0.001; S 100: F2, 15 = 55.72, 
P<0.001) (Figure 9B, C). Which showed that KLF7-SCs promote the myelinated axonal 
regeneration in regenerating ANA. 
ChAT (a marker of motoneurons) and CGRP (a marker of the peptidergic sensory 
neurons) immunostaining provide a reliable method to evaluate the outgrowth rate of motor 
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and sensory axon. The expression of ChAT and CGRP in regenerating ANAs showed similar 
patterns of change in the three groups (ChAT: F2, 15 = 29.17, P<0.001; CGRP: F2, 15 = 27.40, 
P<0.001) (Figure 10A-C). These results demonstrated that KLF7-SCs enhances the 
expression of motor and sensory axonal regeneration markers in regenerating ANAs. 
Retrograde tracer can label neuronal cell bodies in the lumbar L3-L6 DRGs and the 
ventral horn of the L3-L5 spinal cord. When we examined the HRP-labeled motor neurons in 
Rexed lamina IX of the ipsilateral ventral horns (Figure 11A), we found the number of HRP-
labeled motor neurons in the ANA+KLF7-SCs and ANA+SCs groups was more than that in 
the ANA control group. Moreover, the HRP-labeled motor neurons in the ANA+KLF7-SCs 
group was markedly higher than in ANA+SCs group (F2, 6 = 28.27, P<0.001) (Figure 11C). 
We found the presentation of a number of CTB-labeled sensory neurons in the L3-L6 
ipsilateral DRG showed similar patterns of change across each group (F2, 6 = 27.62, P<0.001) 
(Figure 11B, D).  This finding confirmed that motor and sensory axonal regeneration was 
promoted in the ANA+KLF7-SCs group as evaluated by the retrograde method. 
KLF7-SCs promote target muscle motor endplate and wet weight ratio  
The reinnervation between the regenerated nerve fibers and the target muscle cells 
was verified by the cholinesterase staining of the motor endplate.  To assess KLF7-SC’s 
effects on TA muscle motor function recovery, the motor endplate density in the TA was 
assessed following injury (Figure 12A). We found that the number of motor end plates was 
increased in the ANA+SCs and ANA+KLF7-SCs compared to the ANA group. Motor end 
plate numbers were particularly higher in the ANA+KLF7-SCs group compared to the 
ANA+SCs group (F2, 15 = 31.61, P<0.001) (Figure 12B). The above results indicate that 
KLF7-SC’s provide a positive effect on the reinnervation of denervated TA muscle  
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After sciatic nerve injury, the gastrocnemius and anterior tibial muscles began to 
atrophy. We found the weight ratios of target gastrocnemius and anterior tibial muscles were 
increased in the ANA+SCs and ANA+KLF7-SCs compared to the ANA group, the mean 
ratios of gastrocnemius and anterior tibial muscle wet weight were particularly higher in the 
ANA+KLF7-SCs group compared to the ANA+SCs group (gastrocnemius muscle, F2, 15 = 
58.34, P<0.001; anterior tibial muscle, F2, 15 = 44.05, P<0.001) (Figure 12C, D). The above 
results indicate that KLF7-SC’s provide a positive effect on the reverse of the target muscle 
atrophy. 
KLF7-SCs significantly enhances motor function  
Evaluation of sciatic function was carried out according to the sciatic function index 
(SFI). The results showed that SFI values were increased significantly in the ANA+KLF7-
SCs and ANA+SCs group compared to the ANA group on day 28 (Figure 13A). Between 
these groups, a significant increase in SFI value was observed in the ANA+KLF7-SCs group 
compared to the ANA+ SCs group (F2, 21 = 23.03, P<0.001). We next measured the functional 
recovery of the ANAs (Figure 13C) by electrophysiology.  The ANA+KLF7-SCs and 
ANA+SCs groups exhibited an increased CMAP amplitude compared to the ANA group (F2, 
21 = 24.71, P<0.001) (Figure 13D). In contrast, a decreased latency period was found in the 
ANA+KLF7-SCs and ANA+SCs group (F2, 21 = 30.95, P<0.001) (Figure 13E). Furthermore, 
ANA+ KLF7-SCs showed a better electrophysiological response compared to the ANA +SCs 
group.  
The thermal withdraw latency of the ipsilateral hind limb were assessed to determine 
the effect of KLF7-SCs on the pain sensation by Hargreaves’ test (Figure 13B).  The thermal 
hyperalgesia evidenced by the shortening of the withdrawal latencies against thermal 
stimulation was found. The results showed significant hyperalgesia was observed of all 
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treatment groups from the 2 week to 3 week after ANA grafting (2 w, F3, 28 =36.35, P<0.001; 
3 w, F3, 28 = 11.78, P<0.001), the withdrawal latencies in the ANA+KLF7-SCs group showed 
significantly increase on 21 day compare to ANA+SCs and ANA group (F3, 28 = 11.78, 
P<0.001). However, the thermal hyperalgesia was not seen from days 21 to 28. 
Altogether, these data indicated that the KLF7-SCs exhibited the most beneficial 
effects in the context of systematic motor function recovery and pain related behavior. 
 
DISCUSSION 
KLF7 is a transcriptional activator whose expression predominantly plays a role in the 
nervous system (Laub et al., 2006; Zhang et al., 2013). KLF7 can regulate several important 
neurobiological activities such as neurite outgrowth (Caiazzo et al. 2010, Laub et al., 2006), 
cell proliferation (Caiazzo et al., 2010; Zhang et al., 2013), neuronal differentiation (Caiazzo 
et al., 2010), and olfactory bulb development (Caiazzo et al., 2011). Previous studies have 
also confirmed that KLF7 can be activated by nerve injury and can regulate axonal injury 
responses. For example, up-regulation of KLF7 in response to axotomy was previously 
observed during which injured neurons such as RGCs and peripheral DRGs experienced 
regeneration (Veldman et al., 2007; Zou et al., 2009).   
Our previous studies indicated that acellular nerve allografts (ANA) are highly 
biocompatible, capable of reducing the cellular and humoral immunologic response and 
adequately sparing nerve structure and extracellular matrix components which are necessary 
for nerve regeneration (Jia et al., 2012; Wang et al., 2012). We injected AAV2-KLF7 into 
ANA to repair sciatic nerve gap directly, since overexpression of KLF7 has been shown to 
promote motor and sensory axonal regeneration (Wang et al., 2016),  indicating that KLF7 
may enhance axonal growth (Veldman et al., 2007; Moore et al., 2009).  
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As a promising seed cell of nerve grafts, SCs can provide protection and nutrition to the axon 
and promote the formation of myelin sheaths, aiding in physiological and functional recovery. 
SCs also play a crucial role in neural protection, induction of axon growth, guidance and 
production of many neurotrophic factors. Neurotrophic and transcription factors have been 
transferred to SCs and used to enhance the endogenous SCs’ capability to promote nerve 
regeneration and positively affect functional recovery (Fang et al., 2010; Enomoto et al., 
2013; Gravvanis et al., 2007; Deng et al., 2011). However, for the giant nerve gap, there is an 
increasing burden placed on SCs to replicate and survive (Hayashi et al., 2007). Interestingly, 
transcription factors have been previously shown to benefit SCs survival in the peripheral 
nervous system (Wang et al., 2015; Huang et al., 2015; Hoben et al., 2015). KLF7-SCs 
delivery strategies can thus be employed to improve SCs quantity toward the goal of 
enhancing the efficiency of cell transplantation (Hoben et al., 2015). 
In our study, we used engineered SCs overexpression of KLF7 in ANAs to evaluate repair of 
sciatic nerve injury. We found that KLF7-SCs promote native SCs proliferation, consequently 
enhancing axonal growth and myelination. While control SCs expressed a low level of KLF7, 
3 d after AAV2-KLF7 infection, KLF7 was widely co-localized with SCs (labeled by S100) 
and distributed both in the nucleus and cytoplasm of SCs in vitro (Fig. 2A) in the 
experimental group. Further, EdU staining results corroborated that KLF7 overexpression 
promoted SCs proliferation (Fig. 3). Enhanced SC proliferation in response to KLF7 
overexpression may be rooted in the subsequent up-regulation of the trophic and growth 
KLF7 target genes such as NGF, which is known to enhance SCs proliferation (Lei et al., 
2006; Caiazzo et al., 2010).  
In vivo, our results demonstrated that KLF7 protein levels were very low in the intact sciatic 
nerve. The expression of KLF7 in the distal stump of the injured nerve, however, was 
induced by 1 day post-graft, peaking around 1-2 weeks, and returning to normal levels at 
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about 4 week (Fig. 5), indicating that the KLF7 is activated and involved in sciatic nerve 
injury responses after ANA grafting. These results are consistent with former results from 
similar studies performed previously (Veldman et al., 2007). 
KLF7 can regulate several target genes, including the NGF (Caiazzo et al., 2010), TrkA (Lei 
et al., 2001; Lei et al., 2006), TrkB (Kingsbury and Krueger, 2007) and GAP43 (Blackmore et 
al., 2012; Kajimura et al., 2007).  As stated earlier, KLF7 overexpression in SCs likely 
functions therapeutically through the onset of downstream signaling through its various 
growth and repair targets. Indeed, our data confirmed that implantation of KLF7-SCs 
increased the protein expression of KLF7 targets including NGF, TrkA, TrkB and GAP-43 in 
regenerated ANAs (Fig. 6). We therefore speculate that KLF7-SCs may increase 
regeneration-associated genes such as NGF, TrkA, TrkB and GAP-43 and their downstream 
mechanisms, subsequently protecting the transplant from further injury, supplementing 
neurotrophic factors, promoting SCs survival and proliferation–collectively increasing SCs’ 
capability to promote nerve regeneration and functional recovery. That the expression of 
TrkA, TrkB, KLF7, NGF and GAP43 were increased in the grafted SCs may indicate that 
several signaling pathways may converge to mediate a complex injury response, and that 
KLF7 overexpression can influence a range of growth and repair mechanisms. Moreover, the 
number of PKH26-labeled (a transplanted cell tracer) SCs in the ANA were increased in the 
KLF7-SCs group compared to control groups (Fig. 7), indicating that KLF7 improves cellular 
grafting of transplanted SC into the host tissue. 
Various axonal regeneration evaluations were performed in DRG explant cultures. First, we 
note that there was a significant increase in the average length of the longest axons in the 
AAV-KLF7-SCs group compared to AAV-GFP-SCs (Fig.4), indicating that KLF7-SCs 
promote neurite outgrowth in an enhanced capacity compared to SC-transplants alone. In 
vivo, axonal regeneration tests revealed that compared to normal SCs, KLF7-SCs resulted in 
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higher expression of S-100, NF, myelin (P0) proteins, number of myelinated fibers, myelin 
sheath thickness and axon diameters, along with decreased myelin sheath degeneration 
(Figs.7-9). All of these findings indicate that KLF7-SCs treatment, in addition to enhancing 
axonal regeneration through enhancement of SC growth functions, promotes myelinated fiber 
regeneration and myelination in regenerating ANA, aiding in conduction of the fibers at the 
graft site and consequently in functional recovery. 
Sciatic nerve injury is capable of severely impacting sensory and motor functions of the 
lower limbs, impeding functional movement and increasing pain sensation in some cases. As 
such, motor and sensory nerve axons were more closely examined in this study. The motor 
axons at the injured nerve were detected by the motoneuron marker ChAT (Tannemaat et 
al.,2008). Additionally, peptidergic sensory neurons expressing calcitonin gene related 
peptide (CGRP) were detected through the CGRP marker. ChAT and CGRP co- 
immunolabeling are reliable methods to evaluate the outgrowth rate of motor and sensory 
axons (Li et al., 2004; Di Giorgio et al., 2008).  In this study, we found that KLF7-SCs 
treatment increased the density of ChAT and CGRP in regenerating ANAs compared to SCs 
alone (Fig. 10). Additionally, we used retrograde tracers to identify motor and sensory nerve 
regeneration across the lesion gap as previously described (da Silva et al., 1985; 
Koussoulakos et al., 2003).In our study, the retrograde tracer HRP and CTB identified an 
increased number of motor neurons on the L3-L5 ipsilateral ventral horns and an increased 
number of sensory neurons in the L3-L6 DRG in the KLF7-SCs treatment group compared to 
the ANA+SCs group (Fig. 11). These findings suggest that KLF7-SCs may have a significant 
effect on the preservation and/or promotion of motor and sensory axon regeneration, bearing 
important implications for the recovery of critical motor and sensory functions. 
Former studies have reported that sciatic nerve injury induced pain-related behavior (Bester 
et al., 2000). We found here that  ANA grafting of the sciatic nerve gap produces a transient 
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period of thermal hyperalgesia (indicator of nociceptive response), however, the KLF7-SCs 
treatment decreased thermal hyperalgesia 3 weeks after ANA grafting. Due to the expression 
of CGRP receptors on adult SCs, we propose that SC injury response may in part be mediated 
by peripheral nerve injury cues transduced through CGRP signaling sensory neurons (Toth et 
al., 2009). Consequently, considering that CGRP is also a critical player in pain perception 
(Hirose et al., 2010), the upregulation of CGRP expression in ANA may be correlated with 
the observed thermal hyperalgesia which was mitigated by KLF7-SCs (Fig. 13). 
Finally, therapeutic strategies for peripheral nerve injury bear the burden of 
recuperation of critical functions. In addition to an improved pain response, our data 
demonstrate that KLF7-SCs treatment resulted in a significant and progressive recovery of 
physiological and behavioral responses. ANAs grafted with KLF7-SCs demonstrated an 
increased compound action potential amplitude recorded from the medial gastrocnemius and 
plantar muscles. Additionally, latency of the evoked potentials was reduced by the treatment 
compared to controls. Sciatic nerve function was monitored weekly after surgery according to 
the sciatic function index (SFI). As hypothesized, KLF7-SC overexpression improved SFI 
scores, indicating enhancement of sciatic functions. Another parameter of nerve regeneration 
with functional implications was the evaluation of motor endplates and weight of target 
muscles. The experimental treatment resulted in increased fiber density at the endplate in 
addition to increased wet weights of injured muscle at both the gastrocnemius and anterior 
tibal (Figure 12). These findings indicate that muscular atrophy was reduced by the novel 
treatment strategy compared to control treatments. Importantly, across various measures of 
functional outcomes, the KLF7-SC strategy demonstrated superior performance.  
 
CONCLUSION 
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In summary, here we report a novel method of transplanting SCs engineered for the 
overexpression of KLF7 into ANAs for the repair of peripheral nerve injury. This promising 
therapeutic strategy relies mainly on the provision of prolonged transcriptional activation of 
targets that are responsible for the therapeutic mechanisms of  SCs within the injured spinal 
cord, leading to the enhanced motor and sensory axon regeneration, myelination and 
functional recovery reported here. 
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Figure Legends 
Figure 1. Immunohistochemistry of Schwann cells and AAV2-GFP infected (A) SCs cell 
immunohistochemical staining by S-100 (green) and GFAP (red) with nuclear staining 
(DAPI; blue). Merged image showed that SCs were double labeled by S-100 and GFAP. 
Scale bars: 100 μm. (B) AAV2-GFP infected cultured SCs in vitro. Scale bars: 50 μm. (C) 
Quantitative analysis of AAV2-GFP infection rate. 
 
Figure 2. Efficacy of AAV2-KLF7 gene transfer to SCs in vitro 
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(A) Immunohistochemical staining by KLF7 (pink) and S100 (red) with nuclear staining 
(DAPI; blue) of KLF7 transduced SCs. Merged image showed that SCs were double labeled 
by KLF7 and S100. Scale bars: 100 μm. (B) The graphs for the analyses represent the relative 
density of KLF7 in the cultured SCs of two groups are shown at 3 days in vitro. (C) 
Representative Western blot  analysis of KLF7 and NGF expression in the cultured SCs of 
two groups are shown at 3 days in vitro (n = 3).  The graphs for the analyses represent the 
relative density of KLF7 (D) and NGF (E). Error bars denote SD. *P < 0.05, *** P < 0.001, 
vs. the AAV2-GFP group. Student’s t tests. 
 
Figure 3. The proliferation ability of KLF7-SCs and the influence of KLF7- SCs on 
native SCs proliferation  
(A-D) The total number of the cells shown by DAPI (blue) staining, the number of 
proliferating SCs was determined through EdU (red) staining. (E) EdU labeling index of 
AAV2-KLF7 and AAV2-GFP group. (F) In the coculture system, the EdU labeling index of 
SCs in the bottom chambers represented the influence of AAV2-KLF7-SCs and AAV2-GFP-
SCs on native SC proliferation. Error bars denote SD. **P < 0.01, Student’s t tests. Scale bars: 
100 μm. 
 
Figure 4.Effect of KLF7-SCs on neurite outgrowth. (A) Representative immunostaining 
images of DRG explants in each group. Axons were labeled withβ-III-tubulin (green), cell 
nuclei were labeled with DAPI (blue). (B) A comparison of the average length of the five 
longest axons. Error bars denote SD. *** P < 0.001, vs. the Co-AAV2-GFP group. Student’s t 
tests. Scale bars: 100 μm. 
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Figure 5. The expression changes of KLF7 following ANA grafting (A) Western blot 
analysis revealed protein level of KLF7 in normal sciatic nerve (N) and the change of KLF7 
expression in the distal segments of injured sciatic nerve after ANA grafting.  (B) The graphs 
for the analyses represent the KLF7 relative density of the bands normalized to GAPDH in 
different time. n = 3, Error bars denote SD. ***P < 0.001 vs. the normal group. One-way 
ANOVA, Tukey’s post hoc test. 
 
Figure 6. KLF7-SCs significantly increase the expression of KLF7, NGF, GAP43, TrkA, 
and TrkB in regenerating ANAs 
 (A) Representative Western blot analyses of KLF7, NGF, GAP43, TrkA, and TrkB 
expression in ANA tissues harvested 28 days post-injury across three treatment group. The 
graphs for the analyses represent the relative density of KLF7 (B), NGF (C), GAP43 (D), 
TrkA (E), TrkB (F). n = 3 mice/group. Error bars denote SD. *P < 0.05, **P < 0.01, ***P < 
0.001, NS, not significant. One-way ANOVA, Tukey’s post hoc test. 
 
Figure 7.  In longitudinal sections, KLF-SCs significantly increase the expression of P0 
protein (myelination) and transplant SCs survival (PKH26) in regenerating ANAs  
At 28 days post-injury, representative immunohistochemical stainings for P0 (green) and a 
fluorescent tracking dye PKH26 labeled SCs (red) in ANA in longitudinal sections from the 
ANA+KLF7-SCs (A), ANA+SCs group (B) and ANA group (C). n = 6 mice/group. 
Quantitative analyses of PKH26 (D) or P0 (E) expression in immunohistochemical sections.  
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Error bars denote SD. *P < 0.05 ***P < 0.001, One-way ANOVA, Tukey’s post hoc test. Bar 
indicates 100 μm. 
 
Figure 8.  KLF7-SCs promote myelinated fiber regeneration in regenerating ANAs 
Representative Toluidine blue staining (A) and transmission electron microscope (TEM) (B) 
analysis of myelinated fiber regeneration in the regenerating ANAs of three treatment groups 
are shown (n = 6). Quantitative analyses of the number of myelinated fibers (C), the nerve 
myelin sheath thickness (D) and axon diameter (E) in the middle of the ANAs is shown. 
Error bars denote SD. *P < 0.05, **P < 0.01, ***P < 0.001, One-way ANOVA, Tukey’s post 
hoc test. Bar indicates 50 μm. 
 
Figure 9.  KLF7-SCs significantly increase the expression of S-100 protein (myelination) 
and neurofilaments (NF) in ANAs  
(A) Representative immunohistochemical stainings of S-100 and NF protein in ANAs from 
the three treatment groups (n = 8). Merged images combine S-100 (green) and NF (red). 
Quantitative analyses of NF (B) and S-100 (C) expression in immunohistochemical sections. 
Error bars denote SD. ***P < 0.001, One-way ANOVA, Tukey’s post hoc test. Bar bars: 100 
μm. 
 
Figure 10.  KLF7-SCs significantly increase motor and sensory axonal regeneration  
ChAT and CGRP immunostaining evaluated the rate of motor and sensory axon outgrowth. 
(A) Representative immunohistochemical stainings of ChAT and CGRP protein in ANAs 
from the three treatment groups (n = 8). Merged images combine ChAT (red), CGRP (green) 
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and DAPI (bule).Quantitative analyses of ChAT (B) and CGRP (C) expression in 
immunohistochemical sections. Error bars denote SD. **P < 0.01, ***P < 0.001, One-way 
ANOVA, Tukey’s post hoc test. Bar bars: 50 μm. 
 
Figure 11.  Retrograde tracing with HRP and CTB  
Retrograde HRP and CTB labeling from the TA muscle to motor neurons in L3-L5 ipsilateral 
ventral horns or sensory neurons in the L3-L6 DRG were used to evaluate motor and sensory 
axon regeneration. Representative images of the HRP-labeled motor neurons in the ventral 
horns (A) and CTB-labeled DRG sensory neurons (red) (B).  Quantitative analyses of the 
number of HRP-labeled motor neurons detected in L3-L5 spinal cords (C) and CTB labeled 
sensory neurons in the L3-L6 DRG (D). Error bars denote SD. *P < 0.05, **P < 0.01, ***P < 
0.001, One-way ANOVA, Tukey’s post hoc test. Bar indicates 200 μm.  
   
Figure 12. Muscle wet weight and motor endplate analysis. (A) Representative images of 
the motor end plate in the longitudinal section of injured side of TA muscle of each treatment 
group (n = 3).Scale bar, 20 mm. (B) Quantitative analyses of the number of motor end plate 
per TA muscle fiber. Histograms comparing the wet weight ratio of gastrocnemius (C) and 
anterior tibialis muscles (D) of each treatment group (n = 3). Error bars denote SD. **P < 
0.01, ***P < 0.001, One-way ANOVA, Tukey’s post hoc test.  
 
Figure 13.  KLF7-SCs significantly enhanced motor functional recovery of 
regenerating ANAs Quantitative analyses of the sciatic function index (SFI) (A), 
withdrawal latencies according to Hargreaves’ test (B), and electrophysiological index 
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(C), including the compound action potential amplitude (mV) (D) and latency period 
(ms) (E) in ANAs from each group (n = 8) are shown. Error bars denote SD.  *P < 0.05, 
**P < 0.01, ***P < 0.001, One-way ANOVA, Tukey’s post hoc test. 
